BNY Mellon Global Equity Income - C holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
BNY Mellon Global Equity Income Fund - Class C DEQCX
- NAV / 1-Day Return 15.98 / +0.44 %
- Total Assets 198.8M
-
Adj. Expense Ratio
2.040%
- Expense Ratio 2.040%
- Distribution Fee Level High
- Share Class Type Level Load
- Category Global Large-Stock Value
- Investment Style Large Value
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.63%
- Turnover 54%
USD | NAV as of Oct 07, 2026 | 1-Day Return as of Oct 07, 2026, 12:11 AM GMT+0
Morningstar’s Analysis DEQCX
Will DEQCX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 23.7
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Gilead Sciences Inc | 2.99 | 6M | Healthcare |
CME Group Inc Class A | 2.69 | 6M | Financial Services |
AIA Group Ltd | 2.50 | 5M | Financial Services |
UnitedHealth Group Inc | 2.33 | 5M | Healthcare |
GSK PLC | 2.25 | 5M | Healthcare |
Texas Instruments Inc | 2.23 | 5M | Technology |
Smurfit WestRock PLC | 2.22 | 5M | Consumer Cyclical |
Elevance Health Inc | 2.20 | 5M | Healthcare |
Expand Energy Corp Ordinary Shares - New | 2.16 | 5M | Energy |
Barclays PLC | 2.12 | 5M | Financial Services |